HOLLENCREST CAPITAL MANAGEMENT - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 42 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.7%.

Quarter-by-quarter ownership
HOLLENCREST CAPITAL MANAGEMENT ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$256,000
-27.3%
80,355
-2.4%
0.03%
-3.2%
Q1 2022$352,000
-8.1%
82,3550.0%0.03%
+3.3%
Q4 2021$383,000
+126.6%
82,355
+94.4%
0.03%
+100.0%
Q3 2021$169,000
-6.6%
42,3550.0%0.02%
-11.8%
Q2 2021$181,000
+9.7%
42,355
+8.6%
0.02%
+6.2%
Q1 2021$165,000
-13.2%
39,000
-20.4%
0.02%
-20.0%
Q4 2020$190,000
+21.0%
49,000
+25.6%
0.02%
+5.3%
Q3 2020$157,000
+31.9%
39,000
+39.3%
0.02%
+18.8%
Q2 2020$119,000
+183.3%
28,000
+180.0%
0.02%
+166.7%
Q1 2020$42,000
+7.7%
10,0000.0%0.01%
+50.0%
Q4 2019$39,000
-55.7%
10,0000.0%0.00%
-63.6%
Q3 2019$88,000
-5.4%
10,0000.0%0.01%
-8.3%
Q2 2019$93,000
+45.3%
10,0000.0%0.01%
+33.3%
Q1 2019$64,0000.0%10,0000.0%0.01%0.0%
Q4 2018$64,0000.0%10,0000.0%0.01%0.0%
Q3 2018$64,000
-80.1%
10,000
-9.1%
0.01%
-79.1%
Q2 2018$321,000
-58.2%
11,000
-50.2%
0.04%
-59.4%
Q3 2017$768,000
+16.7%
22,0920.0%0.11%
+7.1%
Q2 2017$658,000
-0.2%
22,0920.0%0.10%
+3.1%
Q1 2017$659,000
+70.3%
22,0920.0%0.10%
+65.5%
Q4 2016$387,000
-26.4%
22,0920.0%0.06%
-23.7%
Q3 2016$526,000
+49.0%
22,0920.0%0.08%
+40.7%
Q2 2016$353,000
-23.6%
22,0920.0%0.05%
-30.8%
Q1 2016$462,000
-22.5%
22,0920.0%0.08%
-25.7%
Q4 2015$596,000
-52.4%
22,092
-50.9%
0.10%
-51.6%
Q3 2015$1,251,000
+13.4%
45,0000.0%0.22%
+36.5%
Q2 2015$1,103,000
+33.9%
45,0000.0%0.16%
+45.9%
Q1 2015$824,00045,0000.11%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders